# ABL Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/abl-bio

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.ablbio.com
- Total disclosed funding: $90M
- Latest round: Series C (Jun 8, 2018)
- Investors on record: 15

## About

Established in 2016 and based in Gyeonggi-Do, South Korea, ABL Bio, Inc. is a biotechnology research firm developing therapeutic drugs for immuno-oncology & neurodegenerative diseases. In January 2026, ABL Bio, Inc. raised KRW 21.72 billion in PIPE funding from Eli Lilly & Company. The company plans to use the funding from January 2026 to support the research and development of its technology, enhance its Grabody platform, and develop bispecific ADCs.

## Funding rounds

- Series C, Jun 8, 2018, $65M — Smilegate Investment, IMM Investment, QUAD Investment Management, Hana Securities, COMES Investment, AlpenRoute Asset Management, NewFlight, Susung Asset Management, PTR Asset Management, DS Asset Management
- Series B, Mar 31, 2017, $18M — Korea Investment Partners, KDB Capital, DSC Investment, Timefolio Capital, Paratus Investment
- Series A, Mar 31, 2016, $7.5M — Korea Investment Partners, DSC Investment

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A, Series B
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Series A, Series B
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series B
- Timefolio Capital — Series B
- Paratus Investment (https://capitalatlas.ai/funds/paratus-investment) — Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series C
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series C
- QUAD Investment Management (https://capitalatlas.ai/funds/quad-investment-management) — Series C
- Hana Securities (https://capitalatlas.ai/funds/hana-securities) — Series C
- COMES Investment (https://capitalatlas.ai/funds/comes-investment) — Series C
- AlpenRoute Asset Management — Series C
- NewFlight — Series C
- Susung Asset Management (https://capitalatlas.ai/funds/susung-asset-management) — Series C
- PTR Asset Management — Series C
- DS Asset Management (https://capitalatlas.ai/funds/ds-asset-management) — Series C